Common Contracts
3 similar Indenture contracts by Akoustis Technologies, Inc., Orexigen Therapeutics, Inc., Teligent, Inc.
Teligent, Inc. (Company) The Subsidiary Guarantors named herein (Subsidiary Guarantors) Wilmington Trust, National Association (Trustee and Collateral Agent) INDENTURE Dated as of July 20, 2020Indenture • July 20th, 2020 • Teligent, Inc. • Pharmaceutical preparations • New York
THE GUARANTORS LISTED HEREIN, AND THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A., as Trustee and Collateral Agent INDENTURE Dated as of May 14, 2018 6.5% CONVERTIBLE SENIOR SECURED NOTES DUE 2023Indenture • May 15th, 2018 • Akoustis Technologies, Inc. • Telephone & telegraph apparatus • New York
INDENTURE dated as of May 14, 2018, by and among Akoustis Technologies, Inc., a Delaware corporation (including any successors or assigns), the Guarantors (as defined below), The Bank of New York Mellon Trust Company, N.A., a national banking association, as Trustee and The Bank of New York Mellon Trust Company, N.A., a national banking association, as Collateral Agent.
OREXIGEN THERAPEUTICS, INC. AND U.S. BANK NATIONAL ASSOCIATION, as Trustee and Collateral Agent INDENTURE Dated as of March [●], 2016 0% Convertible Senior Secured Notes due 2020Indenture • March 15th, 2016 • Orexigen Therapeutics, Inc. • Pharmaceutical preparations • New York
INDENTURE dated as of March [●], 2016 between OREXIGEN THERAPEUTICS, INC., a Delaware corporation, as issuer (the “Company,” as more fully set forth in Section 1.01) and U.S. BANK NATIONAL ASSOCIATION, a national banking association organized and existing under the laws of the United States of America, as trustee (in such capacity, the “Trustee,” as more fully set forth in Section 1.01), collateral agent (in such capacity, the “Collateral Agent,” as more fully set forth in Section 1.01) Note Registrar, Paying Agent and Conversion Agent.
